ColBar LifeScience Ltd. Completes $7.25 Million Round Led By Vitalife; Vitalife Joins Existing Investors Pitango, Evergreen, Genesis And Biomedical Investments In Current Round
10/19/2005 5:10:19 PM
Colbar, the Israeli manufacturer of reconstructive medicine and tissue engineering products, today announced the completion of a $7.25 million financing round. Vitalife, the Israeli life sciences venture capital fund, led the round and was joined by previous investors Pitango Venture Capital, Evergreen Partners, Genesis Partners, and Biomedical Investments.
comments powered by